Skip to content

Pacific Biosciences of California PACB Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

Revvity logo
RevvityRVTY
Agilent Technologies logo
Agilent TechnologiesA
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Azenta logo
AzentaAZTA
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Bruker logo
BrukerBRKR

Other financials

Income statement

See full
Revenue$37.2M+0.1%
Gross profit$12.8M+1,037%
Operating income-$8.4M+98.1%
Net income-$8.3M+98.1%
EPS (diluted)-$0.03+97.9%

Balance sheet

See full
Cash & equivalents$57.9M-4.7%
Total debt$59.3M+12.1%
Total equity$2.4M-97.4%
Total assets$782.4M-9.1%

Cash flow

See full
Operating cash flow-$44.7M-1.4%
CapEx$3.0M+119%
Free cash flow-$47.7M-5.0%

Valuation

See full
Market cap$496.96M+30.4%
Enterprise value$498.38M+33.5%
P/S3.1×+0.6×

Profitability

See full
Gross margin37.5%+21.3pp
Operating margin-83.3%-38.2pp
Net margin-80.3%-36.1pp
FCF margin-72.6%-20.0pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio5.7×-1.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacific Biosciences of California's preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacific Biosciences of California's preferred stock, shares authorized?
Pacific Biosciences of California (PACB) reported preferred stock, shares authorized of $50M in Q1 2026.
How has Pacific Biosciences of California's preferred stock, shares authorized changed year-over-year?
Pacific Biosciences of California's preferred stock, shares authorized decreased by 0.0% year-over-year, from $50M to $50M.
What is the long-term trend for Pacific Biosciences of California's preferred stock, shares authorized?
Over 5 years (2020 to 2025), Pacific Biosciences of California's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $50M to $50M.